Multiple human papillomavirus infections are highly prevalent in the anal canal of human immunodeficiency virus-positive men who have sex with men

Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its incidence among HIV+ Men who have Sex with Men (MSM) has been shown, despite the introduction of Highly Active Anti-Retroviral Therapy (HAART). Huma...

Full description

Saved in:
Bibliographic Details
Published inBMC infectious diseases Vol. 14; no. 1; p. 671
Main Authors Méndez-Martínez, Rocío, Rivera-Martínez, Norma E, Crabtree-Ramírez, Brenda, Sierra-Madero, Juan G, Caro-Vega, Yanink, Galván, Silvia C, de León, David Cantú, García-Carrancá, Alejandro
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 16.12.2014
BioMed Central
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its incidence among HIV+ Men who have Sex with Men (MSM) has been shown, despite the introduction of Highly Active Anti-Retroviral Therapy (HAART). Human Papillomavirus (HPV) infections are highly prevalent among HIV+ MSM and recent studies have shown high rates of HPV-associated anal intraepithelial neoplasia (AIN) and anal cancer among this population. In the present study we determined the prevalence and nature of HPV co-infections in the anal canal of 324 HIV+ MSM attending a high specialty medical center in Mexico City, DNA extraction and amplification with generic primers for HPV was performed, followed by detection of specific types and co-infections with INNO-Lipa, and identification of variants by amplification and sequencing of the E6 and LCR region of HPV 16. We found a very high prevalence of HPV infections among this cohort (86%), with more than one fourth of them (28%) positive for type 16. Among HPV16-positive patients, European variants were the most prevalent, followed by Asian-American ones. Among these individuals (HPV-16+), we identified co-infections with other 21 HPV types namely; 11, 51, 52, 6, 66, 68, 74, 18, 45, 35, 26, 44, 70, 53, 54, 82, 31, 33, 56, 58, 59. HIV+ MSM show a very high rate of HPV infections in the anal canal and those with type 16 exhibited a multiplicity of associated types. This study emphasizes the need for an early detection of HPV infections among HIV+ MSM in order to establish its utility to prevent anal neoplasia and cancer.
AbstractList Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its incidence among HIV+ Men who have Sex with Men (MSM) has been shown, despite the introduction of Highly Active Anti-Retroviral Therapy (HAART). Human Papillomavirus (HPV) infections are highly prevalent among HIV+ MSM and recent studies have shown high rates of HPV-associated anal intraepithelial neoplasia (AIN) and anal cancer among this population. In the present study we determined the prevalence and nature of HPV co-infections in the anal canal of 324 HIV+ MSM attending a high specialty medical center in Mexico City, DNA extraction and amplification with generic primers for HPV was performed, followed by detection of specific types and co-infections with INNO-Lipa, and identification of variants by amplification and sequencing of the E6 and LCR region of HPV 16. We found a very high prevalence of HPV infections among this cohort (86%), with more than one fourth of them (28%) positive for type 16. Among HPV16-positive patients, European variants were the most prevalent, followed by Asian-American ones. Among these individuals (HPV-16+), we identified co-infections with other 21 HPV types namely; 11, 51, 52, 6, 66, 68, 74, 18, 45, 35, 26, 44, 70, 53, 54, 82, 31, 33, 56, 58, 59. HIV+ MSM show a very high rate of HPV infections in the anal canal and those with type 16 exhibited a multiplicity of associated types. This study emphasizes the need for an early detection of HPV infections among HIV+ MSM in order to establish its utility to prevent anal neoplasia and cancer.
Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its incidence among HIV+ Men who have Sex with Men (MSM) has been shown, despite the introduction of Highly Active Anti-Retroviral Therapy (HAART). Human Papillomavirus (HPV) infections are highly prevalent among HIV+ MSM and recent studies have shown high rates of HPV-associated anal intraepithelial neoplasia (AIN) and anal cancer among this population. In the present study we determined the prevalence and nature of HPV co-infections in the anal canal of 324 HIV+ MSM attending a high specialty medical center in Mexico City, DNA extraction and amplification with generic primers for HPV was performed, followed by detection of specific types and co-infections with INNO-Lipa, and identification of variants by amplification and sequencing of the E6 and LCR region of HPV 16. We found a very high prevalence of HPV infections among this cohort (86%), with more than one fourth of them (28%) positive for type 16. Among HPV16-positive patients, European variants were the most prevalent, followed by Asian-American ones. Among these individuals (HPV-16+), we identified co-infections with other 21 HPV types namely; 11, 51, 52, 6, 66, 68, 74, 18, 45, 35, 26, 44, 70, 53, 54, 82, 31, 33, 56, 58, 59. HIV+ MSM show a very high rate of HPV infections in the anal canal and those with type 16 exhibited a multiplicity of associated types. This study emphasizes the need for an early detection of HPV infections among HIV+ MSM in order to establish its utility to prevent anal neoplasia and cancer.
Background Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its incidence among HIV+ Men who have Sex with Men (MSM) has been shown, despite the introduction of Highly Active Anti-Retroviral Therapy (HAART). Human Papillomavirus (HPV) infections are highly prevalent among HIV+ MSM and recent studies have shown high rates of HPV-associated anal intraepithelial neoplasia (AIN) and anal cancer among this population. Methods In the present study we determined the prevalence and nature of HPV co-infections in the anal canal of 324 HIV+ MSM attending a high specialty medical center in Mexico City, DNA extraction and amplification with generic primers for HPV was performed, followed by detection of specific types and co-infections with INNO-Lipa, and identification of variants by amplification and sequencing of the E6 and LCR region of HPV 16. Results We found a very high prevalence of HPV infections among this cohort (86%), with more than one fourth of them (28%) positive for type 16. Among HPV16-positive patients, European variants were the most prevalent, followed by Asian-American ones. Among these individuals (HPV-16+), we identified co-infections with other 21 HPV types namely; 11, 51, 52, 6, 66, 68, 74, 18, 45, 35, 26, 44, 70, 53, 54, 82, 31, 33, 56, 58, 59. Conclusions HIV+ MSM show a very high rate of HPV infections in the anal canal and those with type 16 exhibited a multiplicity of associated types. This study emphasizes the need for an early detection of HPV infections among HIV+ MSM in order to establish its utility to prevent anal neoplasia and cancer. Keywords: HIV, HPV, MSM, Type 16, Variants, Anal cancer
Doc number: 671 Abstract Background: Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its incidence among HIV+ Men who have Sex with Men (MSM) has been shown, despite the introduction of Highly Active Anti-Retroviral Therapy (HAART). Human Papillomavirus (HPV) infections are highly prevalent among HIV+ MSM and recent studies have shown high rates of HPV-associated anal intraepithelial neoplasia (AIN) and anal cancer among this population. Methods: In the present study we determined the prevalence and nature of HPV co-infections in the anal canal of 324 HIV+ MSM attending a high specialty medical center in Mexico City, DNA extraction and amplification with generic primers for HPV was performed, followed by detection of specific types and co-infections with INNO-Lipa, and identification of variants by amplification and sequencing of the E6 and LCR region of HPV 16. Results: We found a very high prevalence of HPV infections among this cohort (86%), with more than one fourth of them (28%) positive for type 16. Among HPV16-positive patients, European variants were the most prevalent, followed by Asian-American ones. Among these individuals (HPV-16+), we identified co-infections with other 21 HPV types namely; 11, 51, 52, 6, 66, 68, 74, 18, 45, 35, 26, 44, 70, 53, 54, 82, 31, 33, 56, 58, 59. Conclusions: HIV+ MSM show a very high rate of HPV infections in the anal canal and those with type 16 exhibited a multiplicity of associated types. This study emphasizes the need for an early detection of HPV infections among HIV+ MSM in order to establish its utility to prevent anal neoplasia and cancer.
BACKGROUND: Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its incidence among HIV+ Men who have Sex with Men (MSM) has been shown, despite the introduction of Highly Active Anti-Retroviral Therapy (HAART). Human Papillomavirus (HPV) infections are highly prevalent among HIV+ MSM and recent studies have shown high rates of HPV-associated anal intraepithelial neoplasia (AIN) and anal cancer among this population. METHODS: In the present study we determined the prevalence and nature of HPV co-infections in the anal canal of 324 HIV+ MSM attending a high specialty medical center in Mexico City, DNA extraction and amplification with generic primers for HPV was performed, followed by detection of specific types and co-infections with INNO-Lipa, and identification of variants by amplification and sequencing of the E6 and LCR region of HPV 16. RESULTS: We found a very high prevalence of HPV infections among this cohort (86%), with more than one fourth of them (28%) positive for type 16. Among HPV16-positive patients, European variants were the most prevalent, followed by Asian-American ones. Among these individuals (HPV-16+), we identified co-infections with other 21 HPV types namely; 11, 51, 52, 6, 66, 68, 74, 18, 45, 35, 26, 44, 70, 53, 54, 82, 31, 33, 56, 58, 59. CONCLUSIONS: HIV+ MSM show a very high rate of HPV infections in the anal canal and those with type 16 exhibited a multiplicity of associated types. This study emphasizes the need for an early detection of HPV infections among HIV+ MSM in order to establish its utility to prevent anal neoplasia and cancer.
BACKGROUNDAnal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its incidence among HIV+ Men who have Sex with Men (MSM) has been shown, despite the introduction of Highly Active Anti-Retroviral Therapy (HAART). Human Papillomavirus (HPV) infections are highly prevalent among HIV+ MSM and recent studies have shown high rates of HPV-associated anal intraepithelial neoplasia (AIN) and anal cancer among this population.METHODSIn the present study we determined the prevalence and nature of HPV co-infections in the anal canal of 324 HIV+ MSM attending a high specialty medical center in Mexico City, DNA extraction and amplification with generic primers for HPV was performed, followed by detection of specific types and co-infections with INNO-Lipa, and identification of variants by amplification and sequencing of the E6 and LCR region of HPV 16.RESULTSWe found a very high prevalence of HPV infections among this cohort (86%), with more than one fourth of them (28%) positive for type 16. Among HPV16-positive patients, European variants were the most prevalent, followed by Asian-American ones. Among these individuals (HPV-16+), we identified co-infections with other 21 HPV types namely; 11, 51, 52, 6, 66, 68, 74, 18, 45, 35, 26, 44, 70, 53, 54, 82, 31, 33, 56, 58, 59.CONCLUSIONSHIV+ MSM show a very high rate of HPV infections in the anal canal and those with type 16 exhibited a multiplicity of associated types. This study emphasizes the need for an early detection of HPV infections among HIV+ MSM in order to establish its utility to prevent anal neoplasia and cancer.
ArticleNumber 671
Audience Academic
Author García-Carrancá, Alejandro
Caro-Vega, Yanink
de León, David Cantú
Crabtree-Ramírez, Brenda
Méndez-Martínez, Rocío
Rivera-Martínez, Norma E
Galván, Silvia C
Sierra-Madero, Juan G
Author_xml – sequence: 1
  givenname: Rocío
  surname: Méndez-Martínez
  fullname: Méndez-Martínez, Rocío
  email: rocmenmar@yahoo.com
  organization: División de Investigación, Instituto Nacional de Cancerología, Secretaría de Salud (SSA), México D.F., Mexico. rocmenmar@yahoo.com
– sequence: 2
  givenname: Norma E
  surname: Rivera-Martínez
  fullname: Rivera-Martínez, Norma E
  email: normaerm@hotmail.com
  organization: Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán," SSA, México D.F., Mexico. normaerm@hotmail.com
– sequence: 3
  givenname: Brenda
  surname: Crabtree-Ramírez
  fullname: Crabtree-Ramírez, Brenda
  email: brendcrabtree@hotmail.com
  organization: Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán," SSA, México D.F., Mexico. brendcrabtree@hotmail.com
– sequence: 4
  givenname: Juan G
  surname: Sierra-Madero
  fullname: Sierra-Madero, Juan G
  email: jsmadero@yahoo.com
  organization: Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán," SSA, México D.F., Mexico. jsmadero@yahoo.com
– sequence: 5
  givenname: Yanink
  surname: Caro-Vega
  fullname: Caro-Vega, Yanink
  email: yaninkc@yahoo.com.mx
  organization: Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán," SSA, México D.F., Mexico. yaninkc@yahoo.com.mx
– sequence: 6
  givenname: Silvia C
  surname: Galván
  fullname: Galván, Silvia C
  email: sgalvan@servidor.unam.mx
  organization: Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, México D.F., Mexico. sgalvan@servidor.unam.mx
– sequence: 7
  givenname: David Cantú
  surname: de León
  fullname: de León, David Cantú
  email: dcantu3@excite.com
  organization: Dirección de Investigación Clínica, Instituto Nacional de Cancerología, Secretaría de Salud (SSA), México D.F., Mexico. dcantu3@excite.com
– sequence: 8
  givenname: Alejandro
  surname: García-Carrancá
  fullname: García-Carrancá, Alejandro
  email: carranca@biomedicas.unam.mx, carranca@biomedicas.unam.mx
  organization: Laboratory of Virus & Cancer Instituto Nacional de Cancerología, Av. San Fernando No. 22, Colonia Sección XVI, México D.F., Tlalpan, 14080, México. carranca@biomedicas.unam.mx
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25510243$$D View this record in MEDLINE/PubMed
BookMark eNqNkttq3DAQhk1JaQ7tA_SmCHrTXjjVwZa8N4WQngIpgZ5uhawdrRVkybHsTfY1-sSVs9s0LikUgyzPfPNbmn8Osz0fPGTZc4KPCan4m0hoJRY5JkWOuSB58Sg7IEXaUMaKvXv7_ewwxkuMiajo4km2T8uSYFqwg-zn59ENtnOAmrFVHnWqs86FVq1tP0ZkvQE92OAjUn1i7KpxG9T1sFYO_JDyaGgAKa8c0rdrMDsl27ajD0swVlvweoNuFfMuRDvYNaAWPLpuAmpU-ohwg67t0EzRp9ljo1yEZ7v3Ufb9w_tvp5_y84uPZ6cn53nNKRtyw4FoXJVEcV0uMSeUAqclLOpSMM6FYWZZiaJWmlUpqik1quYYF4wYqirNjrK3W91urFtY6nSfXjnZ9bZV_UYGZeU8420jV2EtCypSAxdJ4N1WoLbhHwLzjA6t3Homk2dy8kwWSebV7hx9uBohDrK1UYNzykMYoyRcCCbKVJfQl3-hl2HsU9snilWcJ2nxh1olk2SyMKS_60lUnpRsUYqSFtPpjx-g0rOE1uo0aMam-Kzg9awgMQPcDCs1xijPvn75f_bix5wlW1b3IcYezF0HCZbTnD_Ysxf3vbur-D3Y7BdDU_uC
CitedBy_id crossref_primary_10_1186_s12992_022_00812_w
crossref_primary_10_1186_s13027_021_00385_0
crossref_primary_10_1002_cam4_2720
crossref_primary_10_1093_annonc_mdv606
crossref_primary_10_1371_journal_pone_0235606
crossref_primary_10_1097_MD_0000000000013201
crossref_primary_10_1371_journal_pone_0197845
crossref_primary_10_1159_000518758
crossref_primary_10_18632_oncotarget_20969
crossref_primary_10_1371_journal_pone_0125120
crossref_primary_10_1016_j_jcv_2018_05_010
crossref_primary_10_1111_hiv_12432
crossref_primary_10_1016_j_pvr_2019_01_002
crossref_primary_10_1016_j_jcol_2016_08_003
crossref_primary_10_3748_wjg_v22_i33_7415
crossref_primary_10_5858_arpa_2017_0563_RA
crossref_primary_10_1016_j_humpath_2022_06_025
crossref_primary_10_1093_cid_ciac044
crossref_primary_10_1016_S2352_3018_19_30434_5
crossref_primary_10_1186_s12879_019_4677_9
crossref_primary_10_1002_cam4_4458
crossref_primary_10_1002_jmv_24943
crossref_primary_10_1002_jmv_24406
crossref_primary_10_1590_1678_4685_gmb_2017_0331
crossref_primary_10_1007_s00705_017_3697_2
crossref_primary_10_1177_0956462416665288
crossref_primary_10_1002_rmv_2219
crossref_primary_10_1080_21645515_2015_1112474
crossref_primary_10_1093_cid_ciy1012
crossref_primary_10_1097_QAI_0000000000002499
crossref_primary_10_1016_j_heliyon_2024_e32336
crossref_primary_10_1590_0074_02760150405
crossref_primary_10_47892_rgp_2024_441_1601
crossref_primary_10_1016_j_jaad_2015_05_040
crossref_primary_10_1186_s12879_016_1706_9
Cites_doi 10.1093/jnci/djg107
10.1128/JCM.01405-13
10.1093/cid/cir064
10.1067/mjd.2000.105158
10.1093/oxfordjournals.jncimonographs.a003484
10.1371/journal.pone.0015256
10.1001/jama.1990.03440210061033
10.1093/jnci/93.17.1325
10.1093/oxfordjournals.jncimonographs.a003479
10.1081/CNV-100102554
10.1128/jvi.71.3.2463-2472.1997
10.1016/j.soc.2003.12.005
10.1093/oxfordjournals.aje.a116420
10.1056/NEJM200104123441503
10.1016/S1470-2045(12)70080-3
10.1016/j.jcv.2012.02.014
10.1097/00042560-199602010-00009
10.1097/00002030-199810000-00010
10.1097/COH.0b013e32831a7246
10.1097/QCO.0b013e3283229fc8
10.1080/00365590050509913
10.1093/jnci/92.18.1500
10.1086/588145
10.1097/00002030-199511000-00007
ContentType Journal Article
Copyright COPYRIGHT 2014 BioMed Central Ltd.
2014 Méndez Martínez et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Méndez Martínez et al.; licensee BioMed Central Ltd. 2014
Copyright_xml – notice: COPYRIGHT 2014 BioMed Central Ltd.
– notice: 2014 Méndez Martínez et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
– notice: Méndez Martínez et al.; licensee BioMed Central Ltd. 2014
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
IOV
ISR
3V.
7QL
7T2
7U9
7X7
7XB
88E
8C1
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
M7N
PIMPY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOI 10.1186/s12879-014-0671-4
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Opposing Viewpoints Resource Center
Science in Context
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Health and Safety Science Abstracts (Full archive)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Databases
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
Environmental Sciences and Pollution Management
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Health & Safety Science Abstracts
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE

Publicly Available Content Database

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2334
EndPage 671
ExternalDocumentID oai_biomedcentral_com_s12879_014_0671_4
3532591021
A539575249
10_1186_s12879_014_0671_4
25510243
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Mexico
GeographicLocations_xml – name: Mexico
GroupedDBID ---
-A0
0R~
23N
2WC
3V.
4.4
53G
5VS
6J9
6PF
7X7
88E
8C1
8FI
8FJ
AAFWJ
AAJSJ
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
ECM
EIF
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
INH
INR
IOV
ISR
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
CITATION
7QL
7T2
7U9
7XB
8FK
AZQEC
C1K
DWQXO
H94
K9.
M7N
PQEST
PQUKI
7X8
ABVAZ
AFGXO
AFNRJ
5PM
ID FETCH-LOGICAL-b623t-f6e1c0851a6c5d06122e625e9b573667f3fd874bac385e9c22fab600431f2a8c3
IEDL.DBID RBZ
ISSN 1471-2334
IngestDate Tue Sep 17 21:25:03 EDT 2024
Wed May 22 07:13:00 EDT 2024
Fri Oct 25 05:54:24 EDT 2024
Thu Oct 10 17:07:06 EDT 2024
Tue Nov 19 21:30:45 EST 2024
Tue Nov 12 23:35:36 EST 2024
Sat Sep 28 21:06:06 EDT 2024
Sat Sep 28 21:07:05 EDT 2024
Thu Sep 12 18:51:37 EDT 2024
Sat Sep 28 07:56:24 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b623t-f6e1c0851a6c5d06122e625e9b573667f3fd874bac385e9c22fab600431f2a8c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://dx.doi.org/10.1186/s12879-014-0671-4
PMID 25510243
PQID 1638668797
PQPubID 42582
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4272559
biomedcentral_primary_oai_biomedcentral_com_s12879_014_0671_4
proquest_miscellaneous_1677375128
proquest_journals_1638668797
gale_infotracmisc_A539575249
gale_infotracacademiconefile_A539575249
gale_incontextgauss_ISR_A539575249
gale_incontextgauss_IOV_A539575249
crossref_primary_10_1186_s12879_014_0671_4
pubmed_primary_25510243
PublicationCentury 2000
PublicationDate 2014-12-16
PublicationDateYYYYMMDD 2014-12-16
PublicationDate_xml – month: 12
  year: 2014
  text: 2014-12-16
  day: 16
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC infectious diseases
PublicationTitleAlternate BMC Infect Dis
PublicationYear 2014
Publisher BioMed Central Ltd
BioMed Central
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
References 23966501 - J Clin Microbiol. 2013 Nov;51(11):3512-20
2160023 - JAMA. 1990 Jun 6;263(21):2911-6
12807947 - J Natl Cancer Inst Monogr. 2003;(31):57-65
11144896 - Scand J Urol Nephrol Suppl. 2000;(205):189-93
22445259 - Lancet Oncol. 2012 May;13(5):487-500
8869947 - Obstet Gynecol Clin North Am. 1996 Sep;23(3):579-95
9677167 - AIDS. 1998 Jul 9;12(10):1177-84
9032384 - J Virol. 1997 Mar;71(3):2463-72
8561979 - AIDS. 1995 Nov;9(11):1255-62
22418456 - J Clin Virol. 2012 Jun;54(2):185-9
19339939 - Curr Opin HIV AIDS. 2009 Jan;4(1):52-6
21364075 - Clin Infect Dis. 2011 May;52(9):1174-81
10954653 - J Am Acad Dermatol. 2000 Sep;43(3):409-32; quiz 433-6
12807939 - J Natl Cancer Inst Monogr. 2003;(31):3-13
8556400 - J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Feb 1;11(2):178-82
1329500 - Am J Epidemiol. 1992 Jul 1;136(1):54-8
19276878 - Curr Opin Infect Dis. 2009 Apr;22(2):109-14
11338884 - Cancer Invest. 2001;19(3):266-72
18426367 - J Infect Dis. 2008 Jun 15;197(12):1676-84
21151900 - PLoS One. 2010;5(12):e15256
10995805 - J Natl Cancer Inst. 2000 Sep 20;92(18):1500-10
11297703 - N Engl J Med. 2001 Apr 12;344(15):1125-31
14652239 - J Natl Cancer Inst. 2003 Dec 3;95(23):1772-83
11535707 - J Natl Cancer Inst. 2001 Sep 5;93(17):1325-30
15137956 - Surg Oncol Clin N Am. 2004 Apr;13(2):263-75
A Nyitray (671_CR19) 2008; 197
ML Gillison (671_CR8) 2003; 31
M Frisch (671_CR11) 2000; 92
671_CR23
FX Bosch (671_CR1) 2003; 31
D Machalek (671_CR18) 2012; 13
H Pfister (671_CR2) 1996; 23
J Mork (671_CR6) 2001; 344
ML Welton (671_CR3) 2004; 13
J Dillner (671_CR4) 2000; 205
M Torres (671_CR17) 2013; 51
L Gao (671_CR10) 2010; 5
A Czelusta (671_CR20) 2000; 43
CS Rabkin (671_CR21) 1992; 136
A Kreutera (671_CR9) 2009; 22
J Palefsky (671_CR12) 2009; 4
JM Palefsky (671_CR14) 1990; 263
CW Critchlow (671_CR16) 1998; 12
A de Pokomandy (671_CR13) 2014; 52
R Herrero (671_CR7) 2003; 95
RP Villanueva (671_CR22) 2002; 27
DM Aboulafia (671_CR5) 2001; 19
J Berumen (671_CR25) 2001; 93
CW Critchlow (671_CR26) 1995; 9
MG Donà (671_CR24) 2012; 54
RJ Biggar (671_CR15) 1996; 11
References_xml – volume: 95
  start-page: 1772
  year: 2003
  ident: 671_CR7
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djg107
  contributor:
    fullname: R Herrero
– volume: 51
  start-page: 3512
  issue: 11
  year: 2013
  ident: 671_CR17
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.01405-13
  contributor:
    fullname: M Torres
– volume: 52
  start-page: 1174
  year: 2014
  ident: 671_CR13
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cir064
  contributor:
    fullname: A de Pokomandy
– volume: 43
  start-page: 409
  year: 2000
  ident: 671_CR20
  publication-title: J Am Acad Dermatol
  doi: 10.1067/mjd.2000.105158
  contributor:
    fullname: A Czelusta
– volume: 31
  start-page: 57
  year: 2003
  ident: 671_CR8
  publication-title: J Natl Cancer Inst Monogr
  doi: 10.1093/oxfordjournals.jncimonographs.a003484
  contributor:
    fullname: ML Gillison
– volume: 23
  start-page: 579
  issue: 3
  year: 1996
  ident: 671_CR2
  publication-title: Obstet Gynecol Clin North Am
  contributor:
    fullname: H Pfister
– volume: 5
  start-page: e15256
  issue: 12
  year: 2010
  ident: 671_CR10
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0015256
  contributor:
    fullname: L Gao
– volume: 27
  start-page: 94
  issue: 4
  year: 2002
  ident: 671_CR22
  publication-title: Bioquímica
  contributor:
    fullname: RP Villanueva
– volume: 263
  start-page: 2911
  year: 1990
  ident: 671_CR14
  publication-title: JAMA
  doi: 10.1001/jama.1990.03440210061033
  contributor:
    fullname: JM Palefsky
– volume: 93
  start-page: 1325
  issue: 17
  year: 2001
  ident: 671_CR25
  publication-title: JNCI
  doi: 10.1093/jnci/93.17.1325
  contributor:
    fullname: J Berumen
– volume: 31
  start-page: 3
  year: 2003
  ident: 671_CR1
  publication-title: J Natl Cancer Inst Monogr
  doi: 10.1093/oxfordjournals.jncimonographs.a003479
  contributor:
    fullname: FX Bosch
– volume: 19
  start-page: 266
  year: 2001
  ident: 671_CR5
  publication-title: Cancer Invest
  doi: 10.1081/CNV-100102554
  contributor:
    fullname: DM Aboulafia
– ident: 671_CR23
  doi: 10.1128/jvi.71.3.2463-2472.1997
– volume: 13
  start-page: 263
  year: 2004
  ident: 671_CR3
  publication-title: Surg Oncol Clin N Am
  doi: 10.1016/j.soc.2003.12.005
  contributor:
    fullname: ML Welton
– volume: 136
  start-page: 54
  year: 1992
  ident: 671_CR21
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a116420
  contributor:
    fullname: CS Rabkin
– volume: 344
  start-page: 1125
  year: 2001
  ident: 671_CR6
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200104123441503
  contributor:
    fullname: J Mork
– volume: 13
  start-page: 487
  year: 2012
  ident: 671_CR18
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(12)70080-3
  contributor:
    fullname: D Machalek
– volume: 54
  start-page: 185
  year: 2012
  ident: 671_CR24
  publication-title: J Clin Virol
  doi: 10.1016/j.jcv.2012.02.014
  contributor:
    fullname: MG Donà
– volume: 11
  start-page: 178
  year: 1996
  ident: 671_CR15
  publication-title: J Acquir Immunodefic Syndr Hum Retrovirol
  doi: 10.1097/00042560-199602010-00009
  contributor:
    fullname: RJ Biggar
– volume: 12
  start-page: 1177
  year: 1998
  ident: 671_CR16
  publication-title: AIDS
  doi: 10.1097/00002030-199810000-00010
  contributor:
    fullname: CW Critchlow
– volume: 4
  start-page: 52
  issue: 1
  year: 2009
  ident: 671_CR12
  publication-title: Curr Opin HIV AIDS
  doi: 10.1097/COH.0b013e32831a7246
  contributor:
    fullname: J Palefsky
– volume: 22
  start-page: 109
  year: 2009
  ident: 671_CR9
  publication-title: Curr Opin Infect Dis
  doi: 10.1097/QCO.0b013e3283229fc8
  contributor:
    fullname: A Kreutera
– volume: 205
  start-page: 189
  year: 2000
  ident: 671_CR4
  publication-title: Scand J Urol Nephrol Suppl
  doi: 10.1080/00365590050509913
  contributor:
    fullname: J Dillner
– volume: 92
  start-page: 1500
  year: 2000
  ident: 671_CR11
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/92.18.1500
  contributor:
    fullname: M Frisch
– volume: 197
  start-page: 1676
  year: 2008
  ident: 671_CR19
  publication-title: J Infect Dis
  doi: 10.1086/588145
  contributor:
    fullname: A Nyitray
– volume: 9
  start-page: 1255
  year: 1995
  ident: 671_CR26
  publication-title: AIDS
  doi: 10.1097/00002030-199511000-00007
  contributor:
    fullname: CW Critchlow
SSID ssj0017829
Score 2.3237066
Snippet Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its...
Background Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in...
Doc number: 671 Abstract Background: Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+)...
BACKGROUNDAnal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in...
BACKGROUND: Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in...
SourceID pubmedcentral
biomedcentral
proquest
gale
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 671
SubjectTerms Acquired immune deficiency syndrome
Adult
AIDS
Anal Canal - virology
Analysis
Antiretroviral Therapy, Highly Active
Antiviral agents
Anus Neoplasms - virology
Cancer
Carcinoma in Situ - virology
Carcinoma, Squamous Cell - virology
Cervical cancer
Coinfection
DNA, Viral - analysis
Drug therapy
Health aspects
HIV
HIV (Viruses)
HIV Infections - drug therapy
HIV Infections - epidemiology
HIV Seropositivity
Homosexuality, Male
Human immunodeficiency virus
Human papillomavirus
Humans
Incidence
Male
Medical centers
Mexico
Middle Aged
Molecular Epidemiology
Oncology, Experimental
Papillomaviridae - genetics
Papillomaviridae - isolation & purification
Papillomavirus Infections - epidemiology
Papillomavirus Infections - virology
Prevalence
Prevalence studies (Epidemiology)
Prevention
SummonAdditionalLinks – databaseName: PubMed Central
  dbid: RPM
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaHhAXRHkGCjIICQkp3c3DdnrgUFVUBWkBAUW9WY4fbKRsEm12W_gb_GJmss6qruDCZbWbGSfejMfzTeYRQl6J0uSmyF3sskTHubNJXBQujy1LFHxxTFusd5595Gfn-YcLdrFD2FgLMyTt67I6bOrFYVPNh9zKbqEnY57Y5PPsJE8FIuHJLtkF8zu66D50ACbvyIcvk4JPetiABaYE5TFszOAvYftfgAnYie9GkXsd2KabO_Q1ExWmT16zR6d3yR0PJOnxZsL7ZMc298itmQ-V3ye_Zz5VkA6v4aOd6qq6bhfqslquezomYTU9VUvgAR-9_kW7JXb_hgsCnQI0pAqvoYfP1vkzVVhS0hqLvSewcJMOZ4w36V-Xli5sQ6_mLZ0r-NHbnxSf9eLRB-T89N23k7PYv4AhLgEVrWLHbaIRkymumUEwlFrwl-xRyUTGuXCZM4XIS6WzAo7qNHWq5BhcTFyqCp09JHtN29jHhLqpFdoZJxJlc2umqjROaTPVWcbKgpmIvA1EIbtNsw2J7a9DCmii3EhVglQlSlXmEXkzim47dPBvCv435pcoXIn9LxpMsPmh1n0v33_6Lo8ZBi4ZOKX_Yvr6JWB67ZlcC5PTyhc1wJ_GvloB50HACVqsQ_K40KTfRXqJWJlzmLuIyIstGUdiZlxj2zXyCJEJgG1FRB5t1uX2BozrPCIiWLHBzQ0poHJDj3GvYk_-e-RTcjtFpUvSOOEHZG-1XNtngN9W5fNBX_8AjvZKyQ
  priority: 500
  providerName: National Library of Medicine
– databaseName: ProQuest Databases
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1rb9Mw0IJOQnxBvCkbyCAkJCRrdR62-wGhgTYNpA40GNo3y_GDVuqSrmkH_A1-MXepW-YJ-BIlvkvi5M7nO9_DhLyQlSucKgILObesCJ4zpULBfMkNnITSesx3Hh2Jw5Piw2l5Ghfc2hhWuZaJnaB2jcU18l3UG4RQcijfzM4Z7hqF3tW4hcZ1spXxXKke2Xq7f_TpeONHgPlvGH2ZXIndFqSxxPiggoGUBuPpSpr7NJmdrsroS5NUGkB5aUY6uE1uRVWS7q1of4dc8_VdcmMUneX3yK9RDBak3UZ8dGZmk-m0OTMXk_mypeswrLqlZg44YKVPf9LZHOt_wwsBTkE5pAbfYbtjE-KTJphU0jiP1ScwdZN2T2SrALALT898Tb-PGzo2cNH6HxRXe7H1Pjk52P_y7pDFLRhYBXrRggXhuUWtzAhbOlSHMg8Wkx9WpcyFkCEPTsmiMjZX0GqzLJhKoHuRh8womz8gvbqp_SNCw8BLG1yQ3PjCu4GpXDDWDWyel5UqXZ-8TkihZ6tyGxoLYKcQ4Au9IqUGUmokpS765NWadJtbOwtHib8hP0fiaqyAUWOIzTezbFv9_uNXvVei67IEs_RfSJ-PE6SXESk00DlrYloDfDRW1kowdxJMGMc2Ba8ZTUc50uo_XN8nzzZgvBNj42rfLBFHylyC4qb65OGKLzc_AAxGjjUn-0QmHJv83BRST8ZdlfEik2huPv5_t7bJzQyHE88YFzukt5gv_RNQ0xbV0zgWfwMkp0Nl
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjR1ra9RAcKkVxC9S37FVVhEEIXrJbnbTD0WKWKpwCupJvy2bffQOrsmZ3NX2b_iLncnj7JYT_BKSzGQ32dnZmck8lpCXsrDc5tzHniUm5t4lcZ57Hrss0XDiM-Mw33n8WRxP-KeT7GSLDNtb9QPYbDTtcD-pST1_c_Hz8h0w_EHL8Ll428AaKzHqh8ew9oJJdIPcTEEwYoTXmP91KoAw3G-TjQAnZYz3Ts6NTVzLf58HYuv64n1FeoWRlVdE1dEOudPrmPSwmxR3yZYr75Fb496Lfp_8HvdRhLTdoY8u9GI2n1dn-nxWrxo6xGeVDdU14ID5Pr-kixoLg0OHAKegNVKNfZj2WPm-pRlmm1TWYVkKzOmkbYtxFxl27uiZK-mvaUWnGi4ad0HxNzDefUAmRx--vz-O-70Z4gIUpmXshUsMqmtamMyinpQ6MKXcfpFJJoT0zNtc8kIblsNdk6ZeFwL9jolPdW7YQ7JdVqV7TKgfOWm89TLRjjs70oX12tiRYSwr8sxG5CAghVp0dTgUVsYOIcCkqiOlAlIqJKXiEXk9kG79aGv65GIT8gskrsLSGCXG3pzqVdOoj19-qMMMfZoZ2Kv_Qvr2NUB61SP5Cl7O6D7fAT4aS24FmHsBJjC4CcHDRFMDfyhUo4WAd5cReb4G45MYNFe6aoU4UjIJGl0ekUfdvFwPAFiSCRajjIgMZmwwuCGknE3b8uM8lWiHPvmfkdolt1NkqiSNE7FHtpf1yj0FLW5ZPGt58w8wbEjA
  priority: 102
  providerName: Scholars Portal
Title Multiple human papillomavirus infections are highly prevalent in the anal canal of human immunodeficiency virus-positive men who have sex with men
URI https://www.ncbi.nlm.nih.gov/pubmed/25510243
https://www.proquest.com/docview/1638668797
https://search.proquest.com/docview/1677375128
http://dx.doi.org/10.1186/s12879-014-0671-4
https://pubmed.ncbi.nlm.nih.gov/PMC4272559
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYJiFeEONrhVEZhISEFFHHju098LBNmwZSByoMVbxYjmPTSl1SNe2Af4O_mLs07eZqPPFiJblf7CTnjzvfRwh5rfJCFFqEJHDmEhE8S7QOIvEZs3AQMucx3rl_Ls8uxMdhNrzOs71hwWdavqthBlXo0yMSmFlB4dkiO6AzcNS0Bkff1yYDWOoOmlAiwKSci9aEeWsVG9Htk2hR2pyab6xNsd_kjYXo9AG530qQ9HDJ8l1yx5cPyd1-ayN_RP70Wx9B2vx_j07tdDyZVJf2ajxb1HTlfVXW1M4AA8r55DedzjDtNzQIdAoyIbXYhmvKKrQ1jTGWpCo8Jp3AiE3a1Jgs_b6uPL30Jf05qujIwkntf1Hc5MWrj8nF6cnX47Ok_fNCkoM4NE-C9MyhMGalywqUglIPipI_yDPFpVSBh0IrkVvHNVx1aRpsLtGqyEJqteNPyHZZlX6P0NDzyoUiKGa98EXP5kWwrug5zrNcZ0WHvI9YYabLLBsG817HFBiCZslKA6w0yEojOuTtinXrWxvFRsvbwK-QuQYTX5ToWfPDLurafPj0zRxmaLHMoGf9C_RlEIHetKBQwcM520YzwEtjQq0IuR8hYfi6mLzqaKadPmqDQrKU8OyqQ16uyXgnusSVvlogRimuQF7THfJ02S_XHwD0RIapJjtERT02-rgxpRyPmuTiIlWoZT77T7Y8J_dSHG8sTZjcJ9vz2cK_APFtnnfJlhoqKPUx65Kdo5Pzz4NusxUCZV_objOsu82-219H0Uv1
link.rule.ids 108,230,314,727,780,784,864,885,2221,12056,12223,21388,24318,24937,27924,27925,31719,31720,33266,33267,33744,33745,43310,43579,43805,53791,53793,75811,75812
linkProvider BioMedCentral
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3rbxMxDI-gk4AviOcoDAgICQkpWu-VpB8QGmjTBmtBY0P7FuXyoJW6u9JrB_wb_MXY17QsE_Clas--R8-OY8f2L4S8EKXNrcw981liWO5dwqT0OXNFouGLL4zDfufBkO-f5O9Pi9Ow4NaEssqVTWwNta0NrpFvo9_AuRR98Wb6jeGuUZhdDVtoXCUbiJxedMjG293hp6N1HgHmv37IZSaSbzdgjQXWB-UMrDQET5fa3CfR7HTZRl-YpOICygsz0t4tcjO4knRnKfvb5Iqr7pBrg5Asv0t-DUKxIG034qNTPR1PJvWZPh_PFg1dlWFVDdUz4IEoffKTTmeI_w03BDoF55BqvIdpP2sfrjTGppLaOkSfwNZN2l6RLQvAzh09cxX9PqrpSMOPxv2guNqLR--Rk73d43f7LGzBwErwi-bMc5cY9Mo0N4VFdyh1EDG5flmIjHPhM2-lyEttMglHTZp6XXJMLyY-1dJk90mnqiv3gFDfc8J460WiXe5sT5fWa2N7JsuKUha2S15HolDTJdyGQgDsmAJ6oZaiVCBKhaJUeZe8WolufWob4Uj-N-bnKFyFCBgVlth81YumUQcfv6idAlOXBYSl_2L6fBQxvQxMvoaHMzq0NcCfRmStiHMr4oRxbGLyStFUsCON-qP1XfJsTcYzsTaucvUCeYTIBDhusks2l3q5fgEQMCaIOdklItLY6OXGlGo8alHG81RguPnw_4_1lFzfPx4cqsOD4YdH5EaKQytJWcK3SGc-W7jH4LLNyydhXP4GZZxGTQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR3LbtNAcAVFqrgg3pgWWBASEpJpbK933QOH8ohaIAUViqpeVut9kKiJHcVJgd_gi5mxN1G2Kiculu0Zr-2dx854HibkuSgNMwVzscsSHTNnk7goHIttnijYcbm2WO88OOT7x-zDSX7iK-uwFqac6GUW0qLxMYrm1Xop-rjV37Cjz3amxnViX_CdBjStwNwfFoMGBsfoKrkGxnArrUdvTlehBVgSd9uSI8BJs4z5UOelQ1yogh8Hi9dFFb62hoX5lWsLVv8mueEtTbrXscYtcsVWt8nmwMfS75A_A59LSNv_9NGpmo7G43qizkezRUOX81M1VM0AB5z48W86nWF7cLghwCnYjlThPXS7rZ0faYQ1J7Wx2JwCKztpO2Lc5YedWzqxFf05rOlQwUFjf1H8GIxn75Lj_vtvb_dj_4eGuASzaR47bhONRpviOjdoLaUWHCq7W-Yi41y4zJlCsFLprICzOk2dKjlGHxOXqkJn98hGVVf2AaGuZ4V2xolEWWZNT5XGKW16OsvysshNRF4HpJDTrhuHxP7YIQT4Q3aklEBKiaSULCIvl6RbXdo6QAW_DPkZEldig4wKM3B-qEXTyIPP3-VejpHNHLzWfyF9PQqQXngkVyPPKl_1AC-NjbcCzO0AE8Rch-Alo0mvZhqJxjTn8OwiIk9XYLwSU-cqCzIEOEJkAuy6IiL3O75cTQD4kwm2pIyICDg2mNwQUo2GbRNylgr0Rh_-J1mekM0v7_ry08Hhxy1yPUXRS9I44dtkYz5b2Edg8c3Lx60E_wWMMliP
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multiple+human+papillomavirus+infections+are+highly+prevalent+in+the+anal+canal+of+human+immunodeficiency+virus-positive+men+who+have+sex+with+men&rft.jtitle=BMC+infectious+diseases&rft.au=M%C3%B1ndez-Mart%C3%ADnez%2C+Roc%C3%ADo&rft.au=Rivera-Mart%C3%ADnez%2C+Norma+E&rft.au=Crabtree-Ram%C3%ADrez%2C+Brenda&rft.au=Sierra-Madero%2C+Juan+G&rft.date=2014-12-16&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2334&rft.eissn=1471-2334&rft.volume=14&rft_id=info:doi/10.1186%2Fs12879-014-0671-4&rft.externalDBID=IOV&rft.externalDocID=A539575249
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2334&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2334&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2334&client=summon